
11 - 50 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
💰 $1.9M Grant on 2022-01
Biotechnology • Pharmaceuticals
Shasqi is a clinical-stage biotech company developing a pre-targeting tumor therapy platform called CAPAC (Click Activated Protodrugs Against Cancer) that uses in‑vivo click chemistry to capture and activate therapeutic payloads at tumors. Their modular approach separates a tumor-binding clickable molecule from an inert clickable payload (radioisotope or chemotherapy protodrug) which becomes activated or locked at the tumor after a bioorthogonal click reaction, aiming to increase tumor drug concentration and reduce systemic toxicity. Shasqi reports clinical validation of the platform and is advancing pipeline assets and collaborations to bring pre‑targeted cancer therapies to patients.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 July 27
Lead and contribute to ADME/PK strategies for next-gen cancer therapies using click chemistry. Collaborate at the interface of chemistry, biology, and translational sciences.
🇺🇸 United States – Remote
💵 $150k - $180k / year
💰 $1.9M Grant on 2022-01
⏰ Full Time
🔴 Lead
🧬 Research Scientist
👻 Ghost score 6%